ESG

A new report reveals a major education gap in obesity care. Informed patients are now demanding options beyond blockbuster drugs like Wegovy and Zepbound.

A new study confirms Algenesis Labs' Soleic® material slashes GHG emissions, offering brands a high-performance, sustainable alternative to petroleum plastics.

Formerly Proven Behavior Solutions, the provider sharpens its focus on autism care, expanding services and launching a major hiring initiative in a competitive market.

A new initiative offers free support for families battling Parkinson's and dementia, aiming to combat the growing, often unseen, crisis of caregiver isolation.

AIRNA has dosed the first patient with AIR-001, an RNA-editing drug that could treat both the lung and liver damage of a devastating genetic disease.

Backed by a $41.3M ARPA-H award, SonoNeu is pioneering sonogenetics, a non-invasive therapy using ultrasound to control cells and treat nerve pain.

A new Montreal-based collaboration aims to use advanced AI and a unique dataset to make drug development faster, smarter, and safer for patients.

A new partnership brings a cost-effective B100 biodiesel solution to the Netherlands, offering fleets an immediate way to slash carbon emissions.

New AI tools from Penguin Ai on Snowflake Marketplace aim to automate prior authorization and medical coding, targeting billions in administrative waste.

Avaí Bio and Austrianova are set to present new findings on a novel cell-based therapy designed to produce the 'longevity protein' Klotho.

A new device from Agiliti aims to prevent painful and costly pressure injuries during surgery, a problem that affects millions and costs billions annually.

Celebrating four decades, HMA excels by helping self-funded employers control rising healthcare costs through a blend of strategic insight, tech, and service.

In a major strategic move, Premier Research appoints Paul Spreen as CCO, signaling a bold push to capture the rebounding biotech market.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

A new AI software that analyzes MRI scans has received a first-of-its-kind FDA classification, promising to help doctors differentiate complex brain disorders.

As Molson Coors preps its Q1 2026 earnings call, all eyes are on its strategy to combat declining volumes and rising costs in a pivotal "reset year."

With new marketing VP Ann Miller, Finite State is building a powerhouse team to lead the booming product security market amid rising regulatory pressures.

Vape giant ELFBAR is winning prestigious design awards for its reusable devices, a strategic pivot addressing sustainability and evolving consumer tastes.

Tech firm unspun is using AI-powered 3D weaving to bring apparel manufacturing back to the U.S., cutting waste and revolutionizing retail supply chains.

With exports soaring to $82 billion, China's massive battery fair will showcase next-gen tech while navigating new mandatory carbon tracking and recycling laws.